Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan G Dolloff

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|April 6, 2022
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myelomaReeder M Robinson, Ashton P Basar, Leticia Reyes, et al.
European Journal of Haematology|May 1, 2012
Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high-dose melphalan in patients with multiple myelomaGiampaolo Talamo, Kevin L Rakszawski, Witold B Rybka, et al.
Cancer Biology & Therapy|July 16, 2011
Spectral imaging-based methods for quantifying autophagy and apoptosisNathan G Dolloff, Xiahong Ma, David T Dicker, et al.
Science Translational Medicine|June 10, 2011
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulationNathan G Dolloff, Patrick A Mayes, Lori S Hart, et al.
Leukemia Research|November 29, 2019
Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivoMarquicia R Pierce, Reeder M Robinson, Tannya R Ibarra-Rivera, et al.
The American Journal of Pathology|October 7, 2011
High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumorsNiklas K Finnberg, Lori S Hart, Nathan G Dolloff, et al.
Biomolecules|January 25, 2025
Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell LymphomaNadia St Thomas, Benjamin N Christopher, Leticia Reyes, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumabLori S Hart, Nathan G Dolloff, David T Dicker, et al.
Molecular Cancer Therapeutics|September 12, 2012
Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9Nathan G Dolloff, Joshua E Allen, David T Dicker, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitorReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|April 6, 2022
PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myelomaReeder M Robinson, Ashton P Basar, Leticia Reyes, et al.
European Journal of Haematology|May 1, 2012
Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high-dose melphalan in patients with multiple myelomaGiampaolo Talamo, Kevin L Rakszawski, Witold B Rybka, et al.
Cancer Biology & Therapy|July 16, 2011
Spectral imaging-based methods for quantifying autophagy and apoptosisNathan G Dolloff, Xiahong Ma, David T Dicker, et al.
Science Translational Medicine|June 10, 2011
Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulationNathan G Dolloff, Patrick A Mayes, Lori S Hart, et al.
Leukemia Research|November 29, 2019
Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivoMarquicia R Pierce, Reeder M Robinson, Tannya R Ibarra-Rivera, et al.
The American Journal of Pathology|October 7, 2011
High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumorsNiklas K Finnberg, Lori S Hart, Nathan G Dolloff, et al.
Biomolecules|January 25, 2025
Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell LymphomaNadia St Thomas, Benjamin N Christopher, Leticia Reyes, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumabLori S Hart, Nathan G Dolloff, David T Dicker, et al.
Molecular Cancer Therapeutics|September 12, 2012
Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9Nathan G Dolloff, Joshua E Allen, David T Dicker, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitorReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Pageof 4